AFMポリクローナル抗体のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global AFM Polyclonal Antibody Market Insights, Forecast to 2028

• レポートコード：QY2207E09409 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のAFMポリクローナル抗体の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にAFMポリクローナル抗体の世界市場のxxx％を占める「ヤギ」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「大学研究室」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のAFMポリクローナル抗体の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのAFMポリクローナル抗体市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのAFMポリクローナル抗体市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 AFMポリクローナル抗体のグローバル主要メーカーには、Abnova、Invitrogen、Proteintech、Abcam、Avantor、Abbexa、Novus Biologicals、Merck、Santa Cruz Biotechnology、American Research Products、Boster Biological Technologyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 AFMポリクローナル抗体市場は、種類と用途によって区分されます。世界のAFMポリクローナル抗体市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ヤギ、ロバ、ウサギ、ラット、その他 【用途別セグメント】 大学研究室、企業研究所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - AFMポリクローナル抗体製品概要 - 種類別市場（ヤギ、ロバ、ウサギ、ラット、その他） - 用途別市場（大学研究室、企業研究所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のAFMポリクローナル抗体販売量予測2017-2028 - 世界のAFMポリクローナル抗体売上予測2017-2028 - AFMポリクローナル抗体の地域別販売量 - AFMポリクローナル抗体の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別AFMポリクローナル抗体販売量 - 主要メーカー別AFMポリクローナル抗体売上 - 主要メーカー別AFMポリクローナル抗体価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（ヤギ、ロバ、ウサギ、ラット、その他） - AFMポリクローナル抗体の種類別販売量 - AFMポリクローナル抗体の種類別売上 - AFMポリクローナル抗体の種類別価格 ・用途別市場規模（大学研究室、企業研究所、その他） - AFMポリクローナル抗体の用途別販売量 - AFMポリクローナル抗体の用途別売上 - AFMポリクローナル抗体の用途別価格 ・北米市場 - 北米のAFMポリクローナル抗体市場規模（種類別、用途別） - 主要国別のAFMポリクローナル抗体市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのAFMポリクローナル抗体市場規模（種類別、用途別） - 主要国別のAFMポリクローナル抗体市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のAFMポリクローナル抗体市場規模（種類別、用途別） - 主要国別のAFMポリクローナル抗体市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のAFMポリクローナル抗体市場規模（種類別、用途別） - 主要国別のAFMポリクローナル抗体市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのAFMポリクローナル抗体市場規模（種類別、用途別） - 主要国別のAFMポリクローナル抗体市場規模（トルコ、サウジアラビア） ・企業情報 Abnova、Invitrogen、Proteintech、Abcam、Avantor、Abbexa、Novus Biologicals、Merck、Santa Cruz Biotechnology、American Research Products、Boster Biological Technology ・産業チェーン及び販売チャネル分析 - AFMポリクローナル抗体の産業チェーン分析 - AFMポリクローナル抗体の原材料 - AFMポリクローナル抗体の生産プロセス - AFMポリクローナル抗体の販売及びマーケティング - AFMポリクローナル抗体の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - AFMポリクローナル抗体の産業動向 - AFMポリクローナル抗体のマーケットドライバー - AFMポリクローナル抗体の課題 - AFMポリクローナル抗体の阻害要因 ・主な調査結果

Market Analysis and Insights: Global AFM Polyclonal Antibody Market
The global AFM Polyclonal Antibody market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Goat accounting for % of the AFM Polyclonal Antibody global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While University Laboratory segment is altered to an % CAGR throughout this forecast period.
China AFM Polyclonal Antibody market size is valued at US$ million in 2021, while the North America and Europe AFM Polyclonal Antibody are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe AFM Polyclonal Antibody landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global AFM Polyclonal Antibody market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global AFM Polyclonal Antibody market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global AFM Polyclonal Antibody market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global AFM Polyclonal Antibody market.
Global AFM Polyclonal Antibody Scope and Market Size
AFM Polyclonal Antibody market is segmented by players, region (country), by Host Type and by Application. Players, stakeholders, and other participants in the global AFM Polyclonal Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Host Type and by Application for the period 2017-2028.
Segment by Host Type
Goat
Donkey
Rabbit
Rat
Others
Segment by Application
University Laboratory
Business Research Institute
Others
By Company
Abnova
Invitrogen
Proteintech
Abcam
Avantor
Abbexa
Novus Biologicals
Merck
Santa Cruz Biotechnology
American Research Products
Boster Biological Technology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

---

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Host Type
1.2.1 Global AFM Polyclonal Antibody Market Size Growth Rate by Host Type, 2017 VS 2021 VS 2028
1.2.2 Goat
1.2.3 Donkey
1.2.4 Rabbit
1.2.5 Rat
1.2.6 Others
1.3 Market by Application
1.3.1 Global AFM Polyclonal Antibody Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 University Laboratory
1.3.3 Business Research Institute
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global AFM Polyclonal Antibody Market Perspective (2017-2028)
2.2 AFM Polyclonal Antibody Growth Trends by Region
2.2.1 AFM Polyclonal Antibody Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 AFM Polyclonal Antibody Historic Market Size by Region (2017-2022)
2.2.3 AFM Polyclonal Antibody Forecasted Market Size by Region (2023-2028)
2.3 AFM Polyclonal Antibody Market Dynamics
2.3.1 AFM Polyclonal Antibody Industry Trends
2.3.2 AFM Polyclonal Antibody Market Drivers
2.3.3 AFM Polyclonal Antibody Market Challenges
2.3.4 AFM Polyclonal Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AFM Polyclonal Antibody Players by Revenue
3.1.1 Global Top AFM Polyclonal Antibody Players by Revenue (2017-2022)
3.1.2 Global AFM Polyclonal Antibody Revenue Market Share by Players (2017-2022)
3.2 Global AFM Polyclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AFM Polyclonal Antibody Revenue
3.4 Global AFM Polyclonal Antibody Market Concentration Ratio
3.4.1 Global AFM Polyclonal Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AFM Polyclonal Antibody Revenue in 2021
3.5 AFM Polyclonal Antibody Key Players Head office and Area Served
3.6 Key Players AFM Polyclonal Antibody Product Solution and Service
3.7 Date of Enter into AFM Polyclonal Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AFM Polyclonal Antibody Breakdown Data by Host Type
4.1 Global AFM Polyclonal Antibody Historic Market Size by Host Type (2017-2022)
4.2 Global AFM Polyclonal Antibody Forecasted Market Size by Host Type (2023-2028)
5 AFM Polyclonal Antibody Breakdown Data by Application
5.1 Global AFM Polyclonal Antibody Historic Market Size by Application (2017-2022)
5.2 Global AFM Polyclonal Antibody Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America AFM Polyclonal Antibody Market Size (2017-2028)
6.2 North America AFM Polyclonal Antibody Market Size by Host Type
6.2.1 North America AFM Polyclonal Antibody Market Size by Host Type (2017-2022)
6.2.2 North America AFM Polyclonal Antibody Market Size by Host Type (2023-2028)
6.2.3 North America AFM Polyclonal Antibody Market Share by Host Type (2017-2028)
6.3 North America AFM Polyclonal Antibody Market Size by Application
6.3.1 North America AFM Polyclonal Antibody Market Size by Application (2017-2022)
6.3.2 North America AFM Polyclonal Antibody Market Size by Application (2023-2028)
6.3.3 North America AFM Polyclonal Antibody Market Share by Application (2017-2028)
6.4 North America AFM Polyclonal Antibody Market Size by Country
6.4.1 North America AFM Polyclonal Antibody Market Size by Country (2017-2022)
6.4.2 North America AFM Polyclonal Antibody Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe AFM Polyclonal Antibody Market Size (2017-2028)
7.2 Europe AFM Polyclonal Antibody Market Size by Host Type
7.2.1 Europe AFM Polyclonal Antibody Market Size by Host Type (2017-2022)
7.2.2 Europe AFM Polyclonal Antibody Market Size by Host Type (2023-2028)
7.2.3 Europe AFM Polyclonal Antibody Market Share by Host Type (2017-2028)
7.3 Europe AFM Polyclonal Antibody Market Size by Application
7.3.1 Europe AFM Polyclonal Antibody Market Size by Application (2017-2022)
7.3.2 Europe AFM Polyclonal Antibody Market Size by Application (2023-2028)
7.3.3 Europe AFM Polyclonal Antibody Market Share by Application (2017-2028)
7.4 Europe AFM Polyclonal Antibody Market Size by Country
7.4.1 Europe AFM Polyclonal Antibody Market Size by Country (2017-2022)
7.4.2 Europe AFM Polyclonal Antibody Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AFM Polyclonal Antibody Market Size (2017-2028)
8.2 Asia-Pacific AFM Polyclonal Antibody Market Size by Host Type
8.2.1 Asia-Pacific AFM Polyclonal Antibody Market Size by Host Type (2017-2022)
8.2.2 Asia-Pacific AFM Polyclonal Antibody Market Size by Host Type (2023-2028)
8.2.3 Asia-Pacific AFM Polyclonal Antibody Market Share by Host Type (2017-2028)
8.3 Asia-Pacific AFM Polyclonal Antibody Market Size by Application
8.3.1 Asia-Pacific AFM Polyclonal Antibody Market Size by Application (2017-2022)
8.3.2 Asia-Pacific AFM Polyclonal Antibody Market Size by Application (2023-2028)
8.3.3 Asia-Pacific AFM Polyclonal Antibody Market Share by Application (2017-2028)
8.4 Asia-Pacific AFM Polyclonal Antibody Market Size by Region
8.4.1 Asia-Pacific AFM Polyclonal Antibody Market Size by Region (2017-2022)
8.4.2 Asia-Pacific AFM Polyclonal Antibody Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America AFM Polyclonal Antibody Market Size (2017-2028)
9.2 Latin America AFM Polyclonal Antibody Market Size by Host Type
9.2.1 Latin America AFM Polyclonal Antibody Market Size by Host Type (2017-2022)
9.2.2 Latin America AFM Polyclonal Antibody Market Size by Host Type (2023-2028)
9.2.3 Latin America AFM Polyclonal Antibody Market Share by Host Type (2017-2028)
9.3 Latin America AFM Polyclonal Antibody Market Size by Application
9.3.1 Latin America AFM Polyclonal Antibody Market Size by Application (2017-2022)
9.3.2 Latin America AFM Polyclonal Antibody Market Size by Application (2023-2028)
9.3.3 Latin America AFM Polyclonal Antibody Market Share by Application (2017-2028)
9.4 Latin America AFM Polyclonal Antibody Market Size by Country
9.4.1 Latin America AFM Polyclonal Antibody Market Size by Country (2017-2022)
9.4.2 Latin America AFM Polyclonal Antibody Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AFM Polyclonal Antibody Market Size (2017-2028)
10.2 Middle East & Africa AFM Polyclonal Antibody Market Size by Host Type
10.2.1 Middle East & Africa AFM Polyclonal Antibody Market Size by Host Type (2017-2022)
10.2.2 Middle East & Africa AFM Polyclonal Antibody Market Size by Host Type (2023-2028)
10.2.3 Middle East & Africa AFM Polyclonal Antibody Market Share by Host Type (2017-2028)
10.3 Middle East & Africa AFM Polyclonal Antibody Market Size by Application
10.3.1 Middle East & Africa AFM Polyclonal Antibody Market Size by Application (2017-2022)
10.3.2 Middle East & Africa AFM Polyclonal Antibody Market Size by Application (2023-2028)
10.3.3 Middle East & Africa AFM Polyclonal Antibody Market Share by Application (2017-2028)
10.4 Middle East & Africa AFM Polyclonal Antibody Market Size by Country
10.4.1 Middle East & Africa AFM Polyclonal Antibody Market Size by Country (2017-2022)
10.4.2 Middle East & Africa AFM Polyclonal Antibody Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abnova
11.1.1 Abnova Company Details
11.1.2 Abnova Business Overview
11.1.3 Abnova AFM Polyclonal Antibody Introduction
11.1.4 Abnova Revenue in AFM Polyclonal Antibody Business (2017-2022)
11.1.5 Abnova Recent Developments
11.2 Invitrogen
11.2.1 Invitrogen Company Details
11.2.2 Invitrogen Business Overview
11.2.3 Invitrogen AFM Polyclonal Antibody Introduction
11.2.4 Invitrogen Revenue in AFM Polyclonal Antibody Business (2017-2022)
11.2.5 Invitrogen Recent Developments
11.3 Proteintech
11.3.1 Proteintech Company Details
11.3.2 Proteintech Business Overview
11.3.3 Proteintech AFM Polyclonal Antibody Introduction
11.3.4 Proteintech Revenue in AFM Polyclonal Antibody Business (2017-2022)
11.3.5 Proteintech Recent Developments
11.4 Abcam
11.4.1 Abcam Company Details
11.4.2 Abcam Business Overview
11.4.3 Abcam AFM Polyclonal Antibody Introduction
11.4.4 Abcam Revenue in AFM Polyclonal Antibody Business (2017-2022)
11.4.5 Abcam Recent Developments
11.5 Avantor
11.5.1 Avantor Company Details
11.5.2 Avantor Business Overview
11.5.3 Avantor AFM Polyclonal Antibody Introduction
11.5.4 Avantor Revenue in AFM Polyclonal Antibody Business (2017-2022)
11.5.5 Avantor Recent Developments
11.6 Abbexa
11.6.1 Abbexa Company Details
11.6.2 Abbexa Business Overview
11.6.3 Abbexa AFM Polyclonal Antibody Introduction
11.6.4 Abbexa Revenue in AFM Polyclonal Antibody Business (2017-2022)
11.6.5 Abbexa Recent Developments
11.7 Novus Biologicals
11.7.1 Novus Biologicals Company Details
11.7.2 Novus Biologicals Business Overview
11.7.3 Novus Biologicals AFM Polyclonal Antibody Introduction
11.7.4 Novus Biologicals Revenue in AFM Polyclonal Antibody Business (2017-2022)
11.7.5 Novus Biologicals Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck AFM Polyclonal Antibody Introduction
11.8.4 Merck Revenue in AFM Polyclonal Antibody Business (2017-2022)
11.8.5 Merck Recent Developments
11.9 Santa Cruz Biotechnology
11.9.1 Santa Cruz Biotechnology Company Details
11.9.2 Santa Cruz Biotechnology Business Overview
11.9.3 Santa Cruz Biotechnology AFM Polyclonal Antibody Introduction
11.9.4 Santa Cruz Biotechnology Revenue in AFM Polyclonal Antibody Business (2017-2022)
11.9.5 Santa Cruz Biotechnology Recent Developments
11.10 American Research Products
11.10.1 American Research Products Company Details
11.10.2 American Research Products Business Overview
11.10.3 American Research Products AFM Polyclonal Antibody Introduction
11.10.4 American Research Products Revenue in AFM Polyclonal Antibody Business (2017-2022)
11.10.5 American Research Products Recent Developments
11.11 Boster Biological Technology
11.11.1 Boster Biological Technology Company Details
11.11.2 Boster Biological Technology Business Overview
11.11.3 Boster Biological Technology AFM Polyclonal Antibody Introduction
11.11.4 Boster Biological Technology Revenue in AFM Polyclonal Antibody Business (2017-2022)
11.11.5 Boster Biological Technology Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global AFM Polyclonal Antibody Market Size Growth Rate by Host Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Goat
Table 3. Key Players of Donkey
Table 4. Key Players of Rabbit
Table 5. Key Players of Rat
Table 6. Key Players of Others
Table 7. Global AFM Polyclonal Antibody Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global AFM Polyclonal Antibody Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global AFM Polyclonal Antibody Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global AFM Polyclonal Antibody Market Share by Region (2017-2022)
Table 11. Global AFM Polyclonal Antibody Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global AFM Polyclonal Antibody Market Share by Region (2023-2028)
Table 13. AFM Polyclonal Antibody Market Trends
Table 14. AFM Polyclonal Antibody Market Drivers
Table 15. AFM Polyclonal Antibody Market Challenges
Table 16. AFM Polyclonal Antibody Market Restraints
Table 17. Global AFM Polyclonal Antibody Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global AFM Polyclonal Antibody Revenue Share by Players (2017-2022)
Table 19. Global Top AFM Polyclonal Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AFM Polyclonal Antibody as of 2021)
Table 20. Ranking of Global Top AFM Polyclonal Antibody Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by AFM Polyclonal Antibody Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players AFM Polyclonal Antibody Product Solution and Service
Table 24. Date of Enter into AFM Polyclonal Antibody Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global AFM Polyclonal Antibody Market Size by Host Type (2017-2022) & (US$ Million)
Table 27. Global AFM Polyclonal Antibody Revenue Market Share by Host Type (2017-2022)
Table 28. Global AFM Polyclonal Antibody Forecasted Market Size by Host Type (2023-2028) & (US$ Million)
Table 29. Global AFM Polyclonal Antibody Revenue Market Share by Host Type (2023-2028)
Table 30. Global AFM Polyclonal Antibody Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global AFM Polyclonal Antibody Revenue Share by Application (2017-2022)
Table 32. Global AFM Polyclonal Antibody Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global AFM Polyclonal Antibody Revenue Share by Application (2023-2028)
Table 34. North America AFM Polyclonal Antibody Market Size by Host Type (2017-2022) & (US$ Million)
Table 35. North America AFM Polyclonal Antibody Market Size by Host Type (2023-2028) & (US$ Million)
Table 36. North America AFM Polyclonal Antibody Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America AFM Polyclonal Antibody Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America AFM Polyclonal Antibody Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America AFM Polyclonal Antibody Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe AFM Polyclonal Antibody Market Size by Host Type (2017-2022) & (US$ Million)
Table 41. Europe AFM Polyclonal Antibody Market Size by Host Type (2023-2028) & (US$ Million)
Table 42. Europe AFM Polyclonal Antibody Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe AFM Polyclonal Antibody Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe AFM Polyclonal Antibody Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe AFM Polyclonal Antibody Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific AFM Polyclonal Antibody Market Size by Host Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific AFM Polyclonal Antibody Market Size by Host Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific AFM Polyclonal Antibody Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific AFM Polyclonal Antibody Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific AFM Polyclonal Antibody Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific AFM Polyclonal Antibody Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America AFM Polyclonal Antibody Market Size by Host Type (2017-2022) & (US$ Million)
Table 53. Latin America AFM Polyclonal Antibody Market Size by Host Type (2023-2028) & (US$ Million)
Table 54. Latin America AFM Polyclonal Antibody Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America AFM Polyclonal Antibody Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America AFM Polyclonal Antibody Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America AFM Polyclonal Antibody Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa AFM Polyclonal Antibody Market Size by Host Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa AFM Polyclonal Antibody Market Size by Host Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa AFM Polyclonal Antibody Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa AFM Polyclonal Antibody Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa AFM Polyclonal Antibody Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa AFM Polyclonal Antibody Market Size by Country (2023-2028) & (US$ Million)
Table 64. Abnova Company Details
Table 65. Abnova Business Overview
Table 66. Abnova AFM Polyclonal Antibody Product
Table 67. Abnova Revenue in AFM Polyclonal Antibody Business (2017-2022) & (US$ Million)
Table 68. Abnova Recent Developments
Table 69. Invitrogen Company Details
Table 70. Invitrogen Business Overview
Table 71. Invitrogen AFM Polyclonal Antibody Product
Table 72. Invitrogen Revenue in AFM Polyclonal Antibody Business (2017-2022) & (US$ Million)
Table 73. Invitrogen Recent Developments
Table 74. Proteintech Company Details
Table 75. Proteintech Business Overview
Table 76. Proteintech AFM Polyclonal Antibody Product
Table 77. Proteintech Revenue in AFM Polyclonal Antibody Business (2017-2022) & (US$ Million)
Table 78. Proteintech Recent Developments
Table 79. Abcam Company Details
Table 80. Abcam Business Overview
Table 81. Abcam AFM Polyclonal Antibody Product
Table 82. Abcam Revenue in AFM Polyclonal Antibody Business (2017-2022) & (US$ Million)
Table 83. Abcam Recent Developments
Table 84. Avantor Company Details
Table 85. Avantor Business Overview
Table 86. Avantor AFM Polyclonal Antibody Product
Table 87. Avantor Revenue in AFM Polyclonal Antibody Business (2017-2022) & (US$ Million)
Table 88. Avantor Recent Developments
Table 89. Abbexa Company Details
Table 90. Abbexa Business Overview
Table 91. Abbexa AFM Polyclonal Antibody Product
Table 92. Abbexa Revenue in AFM Polyclonal Antibody Business (2017-2022) & (US$ Million)
Table 93. Abbexa Recent Developments
Table 94. Novus Biologicals Company Details
Table 95. Novus Biologicals Business Overview
Table 96. Novus Biologicals AFM Polyclonal Antibody Product
Table 97. Novus Biologicals Revenue in AFM Polyclonal Antibody Business (2017-2022) & (US$ Million)
Table 98. Novus Biologicals Recent Developments
Table 99. Merck Company Details
Table 100. Merck Business Overview
Table 101. Merck AFM Polyclonal Antibody Product
Table 102. Merck Revenue in AFM Polyclonal Antibody Business (2017-2022) & (US$ Million)
Table 103. Merck Recent Developments
Table 104. Santa Cruz Biotechnology Company Details
Table 105. Santa Cruz Biotechnology Business Overview
Table 106. Santa Cruz Biotechnology AFM Polyclonal Antibody Product
Table 107. Santa Cruz Biotechnology Revenue in AFM Polyclonal Antibody Business (2017-2022) & (US$ Million)
Table 108. Santa Cruz Biotechnology Recent Developments
Table 109. American Research Products Company Details
Table 110. American Research Products Business Overview
Table 111. American Research Products AFM Polyclonal Antibody Product
Table 112. American Research Products Revenue in AFM Polyclonal Antibody Business (2017-2022) & (US$ Million)
Table 113. American Research Products Recent Developments
Table 114. Boster Biological Technology Company Details
Table 115. Boster Biological Technology Business Overview
Table 116. Boster Biological Technology AFM Polyclonal Antibody Product
Table 117. Boster Biological Technology Revenue in AFM Polyclonal Antibody Business (2017-2022) & (US$ Million)
Table 118. Boster Biological Technology Recent Developments
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global AFM Polyclonal Antibody Market Share by Host Type: 2021 VS 2028
Figure 2. Goat Features
Figure 3. Donkey Features
Figure 4. Rabbit Features
Figure 5. Rat Features
Figure 6. Others Features
Figure 7. Global AFM Polyclonal Antibody Market Share by Application: 2021 VS 2028
Figure 8. University Laboratory Case Studies
Figure 9. Business Research Institute Case Studies
Figure 10. Others Case Studies
Figure 11. AFM Polyclonal Antibody Report Years Considered
Figure 12. Global AFM Polyclonal Antibody Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global AFM Polyclonal Antibody Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global AFM Polyclonal Antibody Market Share by Region: 2021 VS 2028
Figure 15. Global AFM Polyclonal Antibody Market Share by Players in 2021
Figure 16. Global Top AFM Polyclonal Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AFM Polyclonal Antibody as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by AFM Polyclonal Antibody Revenue in 2021
Figure 18. North America AFM Polyclonal Antibody Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America AFM Polyclonal Antibody Market Size Market Share by Host Type (2017-2028)
Figure 20. North America AFM Polyclonal Antibody Market Size Market Share by Application (2017-2028)
Figure 21. North America AFM Polyclonal Antibody Market Size Share by Country (2017-2028)
Figure 22. United States AFM Polyclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada AFM Polyclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe AFM Polyclonal Antibody Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe AFM Polyclonal Antibody Market Size Market Share by Host Type (2017-2028)
Figure 26. Europe AFM Polyclonal Antibody Market Size Market Share by Application (2017-2028)
Figure 27. Europe AFM Polyclonal Antibody Market Size Share by Country (2017-2028)
Figure 28. Germany AFM Polyclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France AFM Polyclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. AFM Polyclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy AFM Polyclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia AFM Polyclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries AFM Polyclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific AFM Polyclonal Antibody Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific AFM Polyclonal Antibody Market Size Market Share by Host Type (2017-2028)
Figure 36. Asia Pacific AFM Polyclonal Antibody Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific AFM Polyclonal Antibody Market Size Share by Region (2017-2028)
Figure 38. China AFM Polyclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan AFM Polyclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea AFM Polyclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia AFM Polyclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India AFM Polyclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia AFM Polyclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America AFM Polyclonal Antibody Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America AFM Polyclonal Antibody Market Size Market Share by Host Type (2017-2028)
Figure 46. Latin America AFM Polyclonal Antibody Market Size Market Share by Application (2017-2028)
Figure 47. Latin America AFM Polyclonal Antibody Market Size Share by Country (2017-2028)
Figure 48. Mexico AFM Polyclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil AFM Polyclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa AFM Polyclonal Antibody Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa AFM Polyclonal Antibody Market Size Market Share by Host Type (2017-2028)
Figure 52. Middle East and Africa AFM Polyclonal Antibody Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa AFM Polyclonal Antibody Market Size Share by Country (2017-2028)
Figure 54. Turkey AFM Polyclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia AFM Polyclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE AFM Polyclonal Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Abnova Revenue Growth Rate in AFM Polyclonal Antibody Business (2017-2022)
Figure 58. Invitrogen Revenue Growth Rate in AFM Polyclonal Antibody Business (2017-2022)
Figure 59. Proteintech Revenue Growth Rate in AFM Polyclonal Antibody Business (2017-2022)
Figure 60. Abcam Revenue Growth Rate in AFM Polyclonal Antibody Business (2017-2022)
Figure 61. Avantor Revenue Growth Rate in AFM Polyclonal Antibody Business (2017-2022)
Figure 62. Abbexa Revenue Growth Rate in AFM Polyclonal Antibody Business (2017-2022)
Figure 63. Novus Biologicals Revenue Growth Rate in AFM Polyclonal Antibody Business (2017-2022)
Figure 64. Merck Revenue Growth Rate in AFM Polyclonal Antibody Business (2017-2022)
Figure 65. Santa Cruz Biotechnology Revenue Growth Rate in AFM Polyclonal Antibody Business (2017-2022)
Figure 66. American Research Products Revenue Growth Rate in AFM Polyclonal Antibody Business (2017-2022)
Figure 67. Boster Biological Technology Revenue Growth Rate in AFM Polyclonal Antibody Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---